Total Payments
$1,261
2024 Payments
$43.06
Companies
13
Transactions
48
Medicare Patients
1,462
Medicare Billing
$315,618
Payment Breakdown by Category
Food & Beverage$1,261 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,261 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $454.14 | 18 | $0 (2019) |
| PFIZER INC. | $172.42 | 11 | $0 (2023) |
| Bard Peripheral Vascular, Inc. | $161.33 | 1 | $0 (2022) |
| PORTOLA PHARMACEUTICALS, LLC | $105.70 | 1 | $0 (2020) |
| Allergan Inc. | $103.56 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $97.29 | 7 | $0 (2022) |
| Amgen Inc. | $43.06 | 1 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $39.41 | 2 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $24.36 | 2 | $0 (2019) |
| BOSTON SCIENTIFIC CORPORATION | $19.41 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43.06 | 1 | Amgen Inc. ($43.06) |
| 2023 | $17.00 | 1 | PFIZER INC. ($17.00) |
| 2022 | $212.55 | 4 | Bard Peripheral Vascular, Inc. ($161.33) |
| 2021 | $13.00 | 1 | Janssen Pharmaceuticals, Inc ($13.00) |
| 2020 | $120.24 | 2 | PORTOLA PHARMACEUTICALS, LLC ($105.70) |
| 2019 | $266.67 | 13 | Allergan Inc. ($103.56) |
| 2018 | $161.26 | 11 | E.R. Squibb & Sons, L.L.C. ($65.26) |
| 2017 | $427.63 | 15 | E.R. Squibb & Sons, L.L.C. ($336.50) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/27/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $43.06 | General |
| 06/01/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/04/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.71 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/28/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.70 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/24/2022 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $161.33 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 03/04/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/18/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/27/2020 | PORTOLA PHARMACEUTICALS, LLC | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $105.70 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 06/28/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.25 | General |
| Category: Cardiovascular | ||||||
| 06/21/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.70 | General |
| Category: Cardiovascular | ||||||
| 06/06/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.58 | General |
| Category: Cardiovascular | ||||||
| 05/20/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.85 | General |
| Category: Cardiovascular | ||||||
| 04/29/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/26/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $103.56 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/21/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/14/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/14/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/08/2019 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Diabetes | ||||||
| 03/01/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/29/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/22/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/12/2018 | BOSTON SCIENTIFIC CORPORATION | ANGIOJET (Device) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: ANGIOPLASTY | ||||||
| 11/21/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.00 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 286 | 756 | $281,758 | $70,687 |
| 2022 | 5 | 329 | 761 | $259,864 | $65,155 |
| 2021 | 5 | 409 | 977 | $570,033 | $84,263 |
| 2020 | 5 | 438 | 1,058 | $768,451 | $95,514 |
Total Patients
1,462
Total Services
3,552
Medicare Billing
$315,618
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 130 | 536 | $203,024 | $52,322 | 25.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 104 | $25,224 | $6,697 | 26.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 65 | 69 | $26,862 | $6,543 | 24.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 27 | $21,030 | $3,899 | 18.5% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 19 | 20 | $5,619 | $1,227 | 21.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 139 | 494 | $169,081 | $42,938 | 25.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 41 | 111 | $26,533 | $6,683 | 25.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 66 | 71 | $25,349 | $6,303 | 24.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 38 | 39 | $25,973 | $6,228 | 24.0% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 45 | 46 | $12,927 | $3,003 | 23.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 157 | 500 | $306,338 | $44,660 | 14.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 60 | 277 | $113,794 | $17,072 | 15.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 58 | 60 | $70,126 | $10,274 | 14.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 102 | 108 | $64,587 | $10,070 | 15.6% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 32 | 32 | $15,187 | $2,187 | 14.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 180 | 642 | $475,786 | $59,098 | 12.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 70 | 218 | $111,723 | $13,893 | 12.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 98 | 106 | $80,953 | $10,071 | 12.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 54 | 55 | $79,173 | $9,854 | 12.4% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Facility | 2020 | 36 | 37 | $20,816 | $2,597 | 12.5% |
About Dr. Qizhi Wang, M.D
Dr. Qizhi Wang, M.D is a Internal Medicine healthcare provider based in Paterson, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2013. The National Provider Identifier (NPI) number assigned to this provider is 1760823355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Qizhi Wang, M.D has received a total of $1,261 in payments from pharmaceutical and medical device companies, with $43.06 received in 2024. These payments were reported across 48 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,261).
As a Medicare-enrolled provider, Wang has provided services to 1,462 Medicare beneficiaries, totaling 3,552 services with total Medicare billing of $315,618. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Paterson, NJ
- Active Since 07/11/2013
- Last Updated 10/31/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1760823355
Products in Payments
- ELIQUIS (Drug) $501.06
- CHANTIX (Drug) $109.43
- ANDEXXA (Biological) $105.70
- DALVANCE (Drug) $103.56
- XARELTO (Drug) $97.29
- LifeVest (Device) $39.41
- ENTRESTO (Drug) $24.36
- ANGIOJET (Device) $19.41
- PREVNAR - 13 (Biological) $16.07
- BASAGLAR (Drug) $12.69
- CUBICIN RF (Drug) $11.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Paterson
Dr. Ramon Sandoval, Md, MD
Internal Medicine — Payments: $24,920
Internal Medicine $24,920
Mr. Luis Luna, Md, MD
Internal Medicine — Payments: $16,210
Internal Medicine $16,210
Dr. Juan Desueza, M.d, M.D
Internal Medicine — Payments: $15,083
Internal Medicine $15,083
Dr. Henry Sherman, M.d, M.D
Internal Medicine — Payments: $11,678
Internal Medicine $11,678
Dr. Gammal Hassanien, Do, DO
Internal Medicine — Payments: $9,502
Internal Medicine $9,502
Mohamed Dahhan, M.d, M.D
Internal Medicine — Payments: $7,770
Internal Medicine $7,770